| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |